APA

Lundberg A. P., Francis J. M., Pajak M., Parkinson E. I., Wycislo K. L., Rosol T. J., Brown M. E., London C. A., Dirikolu L., Hergenrother P. J. & Fan T. M. (20171214). Pharmacokinetics and derivation of an anticancer dosing regimen for the novel anti-cancer agent isobutyl-deoxynyboquinone (IB-DNQ), a NQO1 bioactivatable molecule, in the domestic felid species. : Investigational new drugs.

Chicago

Lundberg Alycen P, Francis Joshua M, Pajak Malgorzata, Parkinson Elizabeth I, Wycislo Kathryn L, Rosol Thomas J, Brown Megan E, London Cheryl A, Dirikolu Levent, Hergenrother Paul J and Fan Timothy M. 20171214. Pharmacokinetics and derivation of an anticancer dosing regimen for the novel anti-cancer agent isobutyl-deoxynyboquinone (IB-DNQ), a NQO1 bioactivatable molecule, in the domestic felid species. : Investigational new drugs.

Harvard

Lundberg A. P., Francis J. M., Pajak M., Parkinson E. I., Wycislo K. L., Rosol T. J., Brown M. E., London C. A., Dirikolu L., Hergenrother P. J. and Fan T. M. (20171214). Pharmacokinetics and derivation of an anticancer dosing regimen for the novel anti-cancer agent isobutyl-deoxynyboquinone (IB-DNQ), a NQO1 bioactivatable molecule, in the domestic felid species. : Investigational new drugs.

MLA

Lundberg Alycen P, Francis Joshua M, Pajak Malgorzata, Parkinson Elizabeth I, Wycislo Kathryn L, Rosol Thomas J, Brown Megan E, London Cheryl A, Dirikolu Levent, Hergenrother Paul J and Fan Timothy M. Pharmacokinetics and derivation of an anticancer dosing regimen for the novel anti-cancer agent isobutyl-deoxynyboquinone (IB-DNQ), a NQO1 bioactivatable molecule, in the domestic felid species. : Investigational new drugs. 20171214.